Frontlight ResearchEarly access
Trial site
Cancer Hospital Affiliated to Harbin Medical University
- 6running trials
The trials here
What the 6 trials at this site are about, from their registry records.
- Conditions
- Lung cancer2 trials
- Triple-negative breast cancer2 trials
- Childhood cancers1 trial
- Colorectal cancer1 trial
- Phase
- Phase 1/23 trials
- Phase 32 trials
- Phase 41 trial
- Status
- Recruiting4 trials
- Active, not recruiting2 trials
- Lead sponsor
- Akeso1 trial
- Beijing InnoCare Pharma Tech Co., Ltd.1 trial
- Haihe Biopharma Co., Ltd.1 trial
- RemeGen Co., Ltd.1 trial
- Shanghai Jiao Tong University School of Medicine1 trial
- and 1 more
Running trials
Recruiting
Active, not recruiting
Recruiting
Recruiting
A Phase I/II Clinical Trial of ICP-723 in the Treatment of Advanced Solid Tumors
Recruiting
Active, not recruiting
Adjuvant Treatment of EC Followed by Taxane +/- Carboplatin in Triple-Negative Breast Cancer
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Lung cancer2 recruiting
- Childhood cancers1 recruiting
- Triple-negative breast cancer1 recruiting
Site data: ClinicalTrials.govUpdated 12 Nov 2026